Software Treatment for Actively Reducing Severity of ADHD in Adults (STARS ADHD Adult)
Public ClinicalTrials.gov record NCT05183919. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Single Arm, Adaptive Design, Pivotal Trial to Assess the Efficacy of AKL-T01, a Novel Digital Intervention Designed to Improve Attention, in Adults Diagnosed With Attention Deficit Hyperactive Disorder
Study identification
- NCT ID
- NCT05183919
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Akili Interactive Labs, Inc.
- Industry
- Enrollment
- 223 participants
Conditions and interventions
Conditions
Interventions
- Digital Treatment Other
Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 28, 2021
- Primary completion
- Jan 12, 2023
- Completion
- Jan 12, 2023
- Last update posted
- Feb 27, 2023
2021 – 2023
United States locations
- U.S. sites
- 14
- U.S. states
- 11
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Melmed Center | Scottsdale | Arizona | 85254 | — |
| CNS Clinical Research Trials | Garden Grove | California | 92845 | — |
| Innovative Clinical Research, Inc. | Lauderhill | Florida | 33319 | — |
| Accel Research Sites | Maitland | Florida | 32751 | — |
| Behavioral Clinical Research, Inc. | Miami Lakes | Florida | 33016 | — |
| Midwest Research Group | Saint Charles | Missouri | 63304 | — |
| Alivation Research | Lincoln | Nebraska | 68526 | — |
| Center for Psychiatry and Behavioral Medicine, Inc. | Las Vegas | Nevada | 89128 | — |
| Hassman Research Institute | Berlin | New Jersey | 08009 | — |
| Albuquerque Neuroscience, Inc. | Albuquerque | New Mexico | 87109 | — |
| MindPath Care Centers | Raleigh | North Carolina | 27606 | — |
| IPS Research | Oklahoma City | Oklahoma | 73106 | — |
| FutureSearch Trials | Dallas | Texas | 75231 | — |
| Southeast Houston Research, Inc. | Houston | Texas | 77089 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05183919, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 27, 2023 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05183919 live on ClinicalTrials.gov.